FIELD: medicine.
SUBSTANCE: invention concerns contrasting agents for magnetic-resonance diagnostics (MRD) of tumours. As a contrasting agent for MRD, there is offered a water-micellar dispersion containing tetra-3-phenylthio-tetra-5-tert-butylphthalocyanine manganese chloride as a contrast substance, and as a surface-active substance, the offered contrasting agent contains block copolymer of ethylene oxide and propylene oxide.
EFFECT: contrasting agent enables a considerably intensified contrast of magnetic-resonance image of a tumour when using minimum doses of contrasting agents introduced.
3 dwg, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONTRAST AGENT FOR MAGNETIC RESONANT TUMOUR DIAGNOSIS | 2012 |
|
RU2499608C1 |
| METHOD OF DIAGNOSTICS OF ONCOLOGIC DISEASES IN EXPERIMENT | 2007 |
|
RU2343828C2 |
| PHOTOSENSITISER BASED ON BACTERIOCHLORIN p DERIVATIVE, METHOD OF OBTAINING BACTERIOCHLORIN p DERIVATIVE AND METHOD OF PHOTODYNAMIC THERAPY OF CANCER WITH APPLICATION OF SAID PHOTOSENSITISER | 2009 |
|
RU2411943C2 |
| METHOD OF DETECTING TUMOR-FEEDING VESSELS IN EXPERIMENT | 2008 |
|
RU2382596C9 |
| MEANS AND METHOD FOR COMBINED CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING IMAGE VISUALIZATION OF BIOMECHANICS OF THE PROCESSES OF INFILTRATION, INVASION AND METASTASIS OF MALIGNANT CELLS | 2020 |
|
RU2761827C1 |
| METHOD FOR PHOTODYNAMIC THERAPY | 2006 |
|
RU2339415C2 |
| PHOTOSENSIBILIZING AGENT, LIPOSOMAL FORMULATION OF PHOTOSENSIBILIZING AGENT AND METHOD FOR CARRYING OUT PHOTODYNAMIC THERAPY | 2004 |
|
RU2257898C1 |
| METHOD FOR OBTAINING CONTRAST-ENHANCED CT IMAGES OF LIVER OF SMALL LABORATORY RODENTS DURING INTRAVITAL RADIATION IMAGING TO ASSES THE PRESENCE AND GROWTH DYNAMICS OF MALIGNANT NEOPLASMS | 2022 |
|
RU2804844C1 |
| DIAGNOSTIC TECHNIQUE FOR GLIOBLASTOMA MULTIFORME BY MAGNETIC RESONANCE TOMOGRAPHY | 2012 |
|
RU2530762C2 |
| INDUCTION HYPERTHERMIA DEVICE USABLE IN EXPERIMENT | 2001 |
|
RU2211713C2 |
